JW (Cayman) Therapeutics Co. Ltd (JWCTF)
OTCMKTS · Delayed Price · Currency is USD
0.3070
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST

JWCTF Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
120671162236841,318
Market Cap Growth
78.78%-42.59%-47.97%-67.35%-48.12%-
Enterprise Value
81-1-6133631,587
Last Close Price
0.310.160.270.501.99-
PS Ratio
4.833.084.7410.57141.07-
PB Ratio
0.950.420.490.651.562.51
P/TBV Ratio
1.750.830.851.052.203.24
EV/Sales Ratio
3.27--0.6174.89-
Debt / Equity Ratio
0.410.360.190.120.050.04
Asset Turnover
0.110.080.070.050.01-
Inventory Turnover
1.342.452.292.431.35-
Quick Ratio
1.441.663.854.579.3111.14
Current Ratio
1.591.744.044.789.5311.17
Return on Equity (ROE)
-51.67%-41.40%-38.04%-32.89%-22.58%-133.78%
Return on Assets (ROA)
-12.23%-14.99%-14.43%-14.75%-13.99%-13.15%
Return on Capital Employed (ROCE)
-35.00%-37.80%-30.30%-28.10%-26.40%-13.20%
Earnings Yield
-71.92%-121.33%-93.23%-54.95%-16.17%-19.33%
FCF Yield
-23.61%-69.57%-49.87%-39.85%-14.60%-4.48%
Buyback Yield / Dilution
-0.58%-0.51%-0.35%-2.59%-203.07%-102.92%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.